The efficacy of carfilzomib and dexamethason (Kd-70) as once-weekly two-drug regimen: The analysis of real-world data from Poland
In real-world clinical practice, the Kd-70 regimen demonstrated an ORR comparable to that observed in the A.R.R.O.W. trial. However, the CR and VGPR rates were lower. These findings underscore the need for further investigation into factors influencing treatment outcomes in this patient population.
Authors
- Magdalena Olszewska‐Szopa
- Anna Czyż (ORCID: https://orcid.org/0000-0001-6641-0182)
- Tomasz Wróbel (ORCID: https://orcid.org/0000-0002-6612-3535)
- Maria Węgrzyn (ORCID: https://orcid.org/0000-0002-5063-9238)
Institutions
- Wroclaw University of Economics and Business (PL)
- Wroclaw Medical University (PL)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2025-10-29
- DOI
- https://doi.org/10.17219/acem/205167
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00